• Welcome
  • General
    Information
  • Course
    Objectives

  • Programme
  • Registration &
    Accommodation

  • Contact

King's Fund London - The Institute of Liver Studies at King's College Hospital invites you to register your interest in this series of courses on the management of patients with chronic viral hepatitis.

The next one day course will be held on 17th May 2013 and feature a world-class faculty in a small group setting to discuss the latest developments and best practice in managing both Hepatitis B and Hepatitis C.

The meeting will take place in the heart of Central London at No.11 Cavendish Square the Home of The King's Fund.

Target audiences: the course will be of benefit for: consultants and senior trainees in Hepatology and Gastroenterology, and other specialists and allied professionals who work with these patient groups.

Please use the tabs above for more information and Register your interest. We hope you will join us.

Dates

11 Cavendish SquareFriday 17th May 2013.

Venue

No.11 Cavendish Square, London

The venue is a Grade II listed Georgian townhouse, with exceptional classic and modern spaces, The Course will use the Burdett Theatre; a new 248 seat conference space with quality and high specification of the facilities. www.11cavendishsq.com

Click here for map and directions

Language

11 Cavendish SquareEnglish is the official language of the Kings Liver Course.

Course Co-ordinators

Dr Kosh Agarwal, Consultant Hepatologist & Transplant Physician/Lead for Hepatitis Institute of Liver Studies, King's College Hospital Foundation Trust/ King's Health Partners.
Dr Will Bernal, Consultant Intensive Care Physician and colleagues from the Institute of Liver Studies, Kings College Hospital.

Recording of the Course

A CD of the slides will be distributed shortly after the Course.

Acknowledgments

Thank you to all the Faculty for their contributions and the venue for their support.

Additionally, the organisers would like to thank the corporate sponsors who have offered unrestricted medical grants in support of the course.

Astellas Boehringer Ingelheim BMS
Gilead Janssen Janssen Terapeutics
MSD   Roche

Sponsorship

The organisers value support from charities and corporate institutions with an interest in supporting patients with liver disease. Please contact the Course Secretariat to discuss option to be involved.

King's FundThe objectives of the courses are to help participants to:

  • gain an understanding of the current, expert management of patients with these conditions.
  • gain an overview of ongoing trials and evolving therapies
  • and provide good value for money!

The courses comprise of lectures from international experts in the field and case based discussions, focussing on what represents best clinical practice in 2013. It provides a unique opportunity for small group discussion of detailed practical management with experts in the field.

Please register your interest via the Contact form.

CPD: 5 points are usually awarded.

Friday 17th May

0830 Coffee    
Session 1 HCV in 2013 Chair: Prof Roger Williams Institute of
Hepatology, London
0930 Welcome Dr Kosh Agarwal Kings College Hospital, London, UK
Licensed Triple Therapy- a year of challenges and promises Prof Geoff Dusheiko Royal Free Hospital, London, UK
0950 The US experience - really easy! Prof Doug Dieterich Mont Sinai Hospital, New York, USA
1010 Discussion and 3 cases with Drs Deepak Joshi, Suman Verma and Phaedra Tachtatzis  
1040 Coffee    
Session 2 Clinical Challenges Dr Abid Suddle Kings College Hospital, London, UK
1100 HIV & HBV/HBV Liver Disease Prof Jurgen Rockstroh University of Bonn, Germany
1120 Cirrhotic patient issues Dr Tarik Asselah Hospital Beaujon,University of Paris Diderot, France
1150 An overview of DAAs and timelines Dr Kosh Agarwal Kings College Hospital, London, UK
1210 Discussion and 3 cases with Drs Ivana Carey, Ashley Barnabas and Kate Child's  
1240 Lunch And Exhibits    
Session 3 EASL Debrief:
New trials and what the future holds
Dr Kosh Agarwal
Kings College Hospital, London, UK
1340 Presentations from companies    
  Janssen Therapeutics
Dr Jonty Manuja,
Scientific Advisor,

Hepatitis Merck Sharp and Dohme
Dr Nadine Chamay,
Senior Scientific Advisor, Virology (HCV-HIV) Medical Affairs

Gilead
Dr Michael Elliott,
Vice President, Medical Affairs, Gilead Sciences (Europe, Asia & Middle East)

Vertex
Dr Michael Aboud,
Country Medical Lead, Janssen Therapeutics EMEA (UK & Ireland)

Boehringer Ingelheim Ltd
Dr Tokunbo Soyemi,
Senior Medical Liason Manager, Medical & Scientific Affairs - Virology

Bristol Myers Squibb
Dr Dimitar Tonev,
Disease Area Head, Virology

 
  Panel discussion with Foster, Dieterich, Asselah, Forton and Foxton  
1510 Coffee    
Session 4 HBV, HCC Dr Matthew Foxton
Chelsea & Westminster and King's College Hospital, London
1540 New data on HBV - Overview Prof Graham Foster Barts and The London School of
Medicine and Dentistry, London
1600 HCC - the future is now Prof Augusto Villaneuva Kings College Hospital, London, UK
1620 Closing Remarks    

Registration

The Registration Fees for the Course are as follows:

Doctors
Early discounted rate prior to 30 April 2013 £75.00 (payment must be received prior to 14th May to retain the discount)
Standard and on site rate £100.00  

Professionals allied to medicine
(specialist nurses, physiotherapists, pharmacists, technicians and medical students)
Early discounted rate prior to 30 April 2013 £40.00 (payment must be received prior to 14th May to retain the discount)
Standard and on site rate £50.00  

The Course Fee includes access to the programme, refreshments, Certificate of Attendance and CD to be distributed shortly after the event.

On-line Registration

  • Registration for this Course is on-line ONLY.
  • Our on-line system allows for payment by cheque, bank transfer, invoice or credit card.
  • ALL PAYMENTS MUST BE RECEIVED PRIOR TO 17TH MAY 2013.
  • If you require an invoice for your payment, please select the invoice option from the system and print off your own invoice.
  • Bookings cannot be made by telephone.

A Cancellation Policy is in place:

  • Cancellations should be made in writing to the Secretariat. E-Mail is acceptable.
  • Cancellations received up to and including 30th April 2013: full refund minus 25% administration charge.
  • Cancellation received from 1st May 2013: no refund.
  • Approved refunds will be processed and issued 60 days after the Meeting.

Accommodation

For details on hotels near the venue, please click the following link

Joining Instructions

Joining Instructions will be issued by E-mail around 10 days before the Course.

Insurance

Neither the Host, the Organisers nor the Course venue can accept responsibility for any loss or injury relating to participants.  All participants are encouraged to obtain their own travel insurance policy to cover the unfortunate possibility of cancellation of Registration.  A Cancellation Policy is in place as regards Registration (see above).

Please contact the course secretariat to receive updated information on future courses.
The conveners of the courses welcome suggestions for future topics in Liver Studies.

 Or Contact Via:

Index Communications Meetings Service
Crown House
28 Winchester Road
Romsey
S051 8AA
UK

Tel: +44 1794 511332

E-Mail: livercourse@Indexcommunications.com

We would like to keep you informed about this Course. By completing the reply form you are authorising the Organisers to add your postal and E-Mail addresses to the contact database.
We do not release our databases to third parties or use cookies on this web site.